Trials / Completed
CompletedNCT01520415
Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients
A Prospective, Randomized, Double-blind, Clinical Trial of Trigger Point Injection Therapy for the Treatment of Myofascial Pain Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Dr. Yoram Shir · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to examine the short and long-term effect of myofascial trigger point injections with either a local anesthetic or saline in patients with chronic low back pain presenting with myofasical pain syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine | 2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit |
| DRUG | Saline | 2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-07-01
- First posted
- 2012-01-30
- Last updated
- 2013-07-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01520415. Inclusion in this directory is not an endorsement.